BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

10th May 2010Adelaide Advertiser Business SectionNext...

  1. manfred1952
    613 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    11/05/10
    09:42
    Post #: 6680390
    10th May 2010
    Adelaide Advertiser Business Section

    Next Step
    Bionomics tests!

    Adelaide biomedical company Bionomics has started the second phase of human clinical trials for its anti-anxiety drug BNC210.

    The company is testing whether food consumption impacts on the blood level of the drug.

    The trials will be at the Royal Adelaide Hospital's Pain and Anaesthesia Research Clinic and are expected to be completed next month.





    BNO Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS View the latest ASX market news here
right-arrow Created with Sketch.
NEWS Marquee declares maiden antimony resource at Eastern Hills with phase two exploration to commence
right-arrow Created with Sketch.
NEWS Strong soil results define new gold targets at Tole and Dadjan
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.